جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.
HA

Hessa Mohammed Alfayadh

بانتظار توثيق الانتساب2024–2025
2وثائق Scopus
12استشهاداً
2مؤشر h
0منها بانتماء الجامعة
إجمالي Scopus (كل الجهات)
مراجعةوصول مفتوح20254استشهاد· Semantic Scholar

Efficacy and safety of tranexamic acid during bariatric surgery: an updated systematic review and meta-analysis of 10 comparative studies

BMC Surgery · مجلد 26 (1) · 69-69

AIM: This study aimed to conduct an updated systematic review and meta-analysis of comparative studies evaluating the efficacy and safety of tranexamic acid (TXA) during bariatric surgery. METHODS: Six databases were searched up to September 2, 2025. The primary endpoint was the rate of postoperative bleeding. Secondary endpoints included transfusion, hematoma, reoperation, thromboembolic events, operative time, and hospital stay. Outcomes were pooled as risk ratios (RR) or mean differences (MD) with 95% confidence intervals (CI) using a random-effects model. RESULTS: Ten studies (11 treatment arms; 2,137 patients, mostly undergoing laparoscopic sleeve gastrectomy) were included. TXA, usually given as a single intravenous dose at induction, was associated with a lower risk of postoperative bleeding (9 studies; RR 0.57, 95% CI 0.36–0.88), although this effect was not robust in leave-one-out sensitivity analyses. No significant differences were observed for blood transfusion, hematoma, or reoperation. TXA modestly reduced operative time and length of stay, but these differences were not clinically important. No thromboembolic events were reported in TXA-treated patients, and overall risk of bias was judged as low to moderate across most studies. CONCLUSION: TXA may reduce postoperative bleeding, but the effect was not robust in sensitivity analyses; though further high-quality RCTs are needed.

tranexamic acidbariatric surgerypostoperative bleedinglaparoscopic sleeve gastrectomy
مراجعةوصول مفتوح20248استشهاد· Semantic Scholar

The Impact of Vitamin D on Androgens and Anabolic Steroids among Adult Males: A Meta-Analytic Review

Diseases · مجلد 12 (10) · 228-228

Background: Recent studies indicate that vitamin D impacts male reproductive function, with deficiency linked to infertility. This review evaluates the effect of vitamin D supplementation on male fertility, focusing on total testosterone, free testosterone, the free androgen index (FAI), follicle-stimulating hormone (FSH), luteinizing hormone (LH), sex-hormone-binding globulin (SHBG), and estradiol. Methods: We systematically searched Medline, Web of Science, Cochrane Library, and Scopus from their inception until July 2024 for randomized controlled trials (RCTs) involving adult males. The primary focus of these studies was on reproductive hormone parameters, analyzed using a random-effects meta-analysis and weighted mean difference (WMD). Evidence quality was assessed using ROB2 and GRADE. Meta-regression and dose–response analyses were performed. Results: Seventeen studies met the criteria for quantitative analysis. Vitamin D supplementation significantly increased total testosterone levels (WMD 0.38, 95% CI 0.06–0.70, n = 15, I2 = 67.03). However, it had no significant effect on other hormone parameters: free testosterone (WMD 0.00, 95% CI −0.02–0.03, n = 9, I2 = 48.12), FSH (WMD −0.02, 95% CI −0.57–0.53, n = 7, I2 = 48.72), LH (WMD −0.09, 95% CI −0.30–0.12, n = 8, I2 = 0.00), SHBG (WMD 0.73, 95% CI −1.14–2.61, n = 10, I2 = 69.05), FAI (WMD −0.92, 95% CI −2.12–0.27, n = 6, I2 = 0.00), and estradiol (WMD −0.02, 95% CI −2.95–2.92, n = 5, I2 = 20.63). Conclusion: This meta-analysis shows that vitamin D supplementation may increase total testosterone levels in men. However, further well-designed RCTs are needed to determine vitamin D’s effects on other reproductive hormone parameters.

vitamin D supplementationandrogensanabolic steroidsmale fertility